Financhill
Sell
37

CNSP Quote, Financials, Valuation and Earnings

Last price:
$0.11
Seasonality move :
-36.7%
Day range:
$0.10 - $0.12
52-week range:
$0.10 - $65.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.94x
Volume:
5.8M
Avg. volume:
6.2M
1-year change:
-99.82%
Market cap:
$6.5M
Revenue:
--
EPS (TTM):
-$70.72

Earnings Data

Next earnings date for CNSP
Apr 01
2025
Most recent earnings per share
-$0.25
Missed by $0.25
(Nov 14/2024)
Consensus Estimate
--
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CNSP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2024 Q4 -- -- -- -- --
11/14/2024 Q3 -- -- -$0.25 -- --
08/14/2024 Q2 -- -- -$6.72 -- --
05/15/2024 Q1 -- -- -$20.50 -- --
12/31/2023 Q4 -- -- -$43.25 -- --
11/15/2023 Q3 -- -- -$54.14 -- --
06/30/2023 Q2 -- -- -$51.86 -- --
03/31/2023 Q1 -- -- -$129.50 -- --
12/31/2022 Q4 -- -- -$177.50 -- --
11/11/2022 Q3 -- -- -$128.00 -- --
08/12/2022 Q2 -- -- -$133.50 -- --
05/13/2022 Q1 -- -- -$122.00 -- --
03/03/2022 Q4 -- -- -$180.00 -- --
11/12/2021 Q3 -- -- -$210.00 -- --
08/13/2021 Q2 -- -- -$225.00 -- --
05/14/2021 Q1 -- -- -$225.00 -- --
03/12/2021 Q4 -- -- -$270.00 -- --
11/12/2020 Q3 -- -- -$180.00 -- --
08/13/2020 Q2 -- -- -$225.00 -- --
05/15/2020 Q1 -- -- -$180.00 -- --
03/12/2020 Q4 -- -- -$255.00 -- --
09/30/2019 Q3 -- -- -$75.00 -- --
06/30/2019 Q2 -- -- -$45.00 -- --
03/31/2019 Q1 -- -- -$23.37 -- --
12/31/2018 Q4 -- -- -$732.84 -- --
09/30/2018 Q3 -- -- -$21.35 -- --
06/30/2018 Q2 -- -- -$24.58 -- --

CNS Pharmaceuticals Earnings Questions

  • How Much did CNS Pharmaceuticals Generate in Revenue Last Quarter?

    CNS Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did CNS Pharmaceuticals Beat Earnings Last Quarter?

    CNS Pharmaceuticals announced earnings per share of -$0.25 which represents a miss of analyst forecast a -- per share.

  • Is CNS Pharmaceuticals Profitable?

    CNS Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for CNS Pharmaceuticals EPS Next Year?

    CNS Pharmaceuticals's earnings are forecast to grow from -$500.00 per share to -- per share next year representing an increase of --.

  • When is CNS Pharmaceuticals's Earnings Date?

    CNS Pharmaceuticals's next earnings date is April 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Tesla Go Up or Down in 2025?
Will Tesla Go Up or Down in 2025?

The last few months have been exciting for Tesla and…

Why Is Coinbase Stock Going Down?
Why Is Coinbase Stock Going Down?

Every way you look at it, Coinbase has had a…

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
54
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
50
LMND alert for Dec 28

Lemonade [LMND] is down 10.69% over the past day.

Sell
50
TSLL alert for Dec 28

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.

Buy
63
SMLR alert for Dec 28

Semler Scientific [SMLR] is down 9.65% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock